Goodwin Procter advised Subject Matter, and Seyfarth Shaw advised Kivvit. Subject Matter, a portfolio company of Coral Tree Partners, announced its acquisition of Kivvit to create...
You must be a Standard 1 Year member to access this content.
King & Spalding is serving as legal counsel to Mubadala, and Paul, Weiss is serving as legal counsel to Brightspeed. Brightspeed and Mubadala Investment Company announced that...
You must be a Standard 1 Year member to access this content.
Latham & Watkins advised 4D Molecular Therapeutics, while Cooley advised the underwriters for the offering. 4D Molecular Therapeutics, Inc. has announced that it priced an upsized...
You must be a Standard 1 Year member to access this content.
Cooley advised SI-BONE on the offering, and Latham & Watkins advised the underwriters involved. SI-BONE, Inc. has announced the pricing of its underwritten public offering of 3,775,000...
You must be a Standard 1 Year member to access this content.
Shearman & Sterling represented Sasol Limited in the offering. Sasol Limited announced that its wholly owned subsidiary Sasol Financing USA LLC has priced an offering of US$-denominated, Rule...
You must be a Standard 1 Year member to access this content.
Browne Jacobson advised Apiary on the deal, while Osborne Clarke advised First Intuition. Apiary Capital has completed a significant investment in First Intuition, the specialist provider...
You must be a Standard 1 Year member to access this content.
Davis Polk advised Clarios International on the offering. Clarios International LP announced a Rule 144A/Regulation S offering of $750 million aggregate principal amount of its 6.750%...
You must be a Standard 1 Year member to access this content.
Davis Polk advised ZJLD Group on the offering, while Cleary Gottlieb advised the joint sponsors, and the overall coordinators, joint global coordinators, joint bookrunners, and joint...
You must be a Standard 1 Year member to access this content.
Goodwin Procter acted as counsel to FibroGen, and Gibson Dunn acted as counsel to Morgan Stanley Tactical Value. FibroGen, Inc. (NASDAQ: FGEN) announced a non-dilutive term...
You must be a Standard 1 Year member to access this content.
Gibson Dunn acted as legal advisor to RTW, and Cooley acted as legal advisor to Milestone. Milestone Pharmaceuticals Inc. announced that it has entered into a...
You must be a Standard 1 Year member to access this content.
Cooley advised Reneo, and Latham & Watkins advised the underwriters and placement agents. Reneo Pharmaceuticals, Inc. announced the pricing of its previously announced underwritten public offering of...
You must be a Standard 1 Year member to access this content.
Latham & Watkins advised Ardian on the deal. Ardian announced the acquisition of a majority stake in LIFTKET Group from Afinum. LIFTKET’s management team, led by CEO...
You must be a Standard 1 Year member to access this content.
